|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00281710 |
|
Date of registration:
|
23/01/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Urinary Aquaporin 2 Excretion After Methylprednisolone in Fasting Healthy Humans
|
|
Scientific title:
|
Urinary Aquaporin 2 Excretion After Methylprednisolone in Fasting Healthy Humans |
|
Date of first enrolment:
|
October 2005 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00281710 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Contacts
|
|
Name:
|
Erling B Pedersen, Professor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Holstebro Hospital, 7500 Holstebro, Denmark |
|
|
Name:
|
Thomas G Knudsen, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Holstebro Sygehus |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- (1) Genders; both mal and female
- (2) Age; 18- 65 years old
- (3) BMI; below 30
- (4) Females had to bee in oral contraceptive treatment
Exclusion Criteria:
- (1) Clinical signs or history of disease in the heart, lungs, kidneys or endocrine
organs
- (2) Abnormal laboratory test (blood haemoglobin, white cell count, platelets, plasma
sodium, plasma potassium, plasma creatinine, plasma albumin, plasma bilirubin,
plasma alanine aminotransferase, plasma cholesterol and blood glucose)
- (3) Albuminuria or glucosuria
- (4) Cancer
- (5) Arterial hypertension
- (6) Alcohol abuse
- (7) Use of tobacco
- (8) Medical treatment, except oral contraceptives
- (9) Pregnancy or breast feeding
- (10) Medicine abuse
- (11) Donation of blood less than 1 month before the study.
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Healthy
|
|
Intervention(s)
|
|
Drug: Methylprednisolone
|
|
Primary Outcome(s)
|
|
FeNa+
|
|
u-AQP-2
|
|
Secondary ID(s)
|
|
MED.RES.HOS.2005.02.TGK
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|